ProCE Banner Activity

Positioning 2-Drug ART in Two Key Treatment Settings

Conference Coverage
Clinical Thought
With longer-term data now available, our understanding of the use for 2-drug regimens in first-line and maintenance ART settings has expanded. Here’s my take on how that affects practice.

Released: February 24, 2020

Expiration: February 22, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Alexandra Calmy, MD, FMH, PhD, has disclosed that she has received fees for non-CME/CE services from Gilead Sciences.